핵심요약

• S&P 500 지수는 올해 7% 상승 중
• HCA Healthcare는 미국 전역에 1,800개 이상의 시설 네트워크 보유
• MercadoLibre는 라틴아메리카 시장에서 50% 이상 시장 점유율 보유
• Visa는 글로벌 결제 시장 점유율 20% 이상
• HCA Healthcare는 노령화 인구 증가로 수요 증가 전망

도입

이 기사는 장기 투자자들에게 현재 주가가 하락한 주요 기업들의 투자 가치를 재평가할 수 있는 기회를 제공합니다. 특히 HCA Healthcare, MercadoLibre, Visa와 같은 선도 기업들은 단기적인 어려움을 겪고 있지만, 장기적인 성장 잠재력이 높다는 점이 핵심입니다.

본문 1: HCA Healthcare의 시장 우위

HCA Healthcare는 미국 전역에 1,800개 이상의 시설 네트워크를 보유하고 있어, 높은 진입 장벽을 형성하고 있습니다. 이 회사는 2025년 기준 5,000억 달러 이상의 매출을 기록하며, 의료 시설 운영 분야에서 선두주자입니다. 노령화 인구 증가라는 세속적 추세(secular tailwind)는 HCA Healthcare의 수요를 지속적으로 증가시킬 것으로 예상됩니다. 이는 회사의 장기적인 수익성 향상에 긍정적인 영향을 미칠 것입니다.

본문 2: MercadoLibre의 경쟁 심화

MercadoLibre는 라틴아메리카 시장에서 50% 이상 시장 점유율을 보유하고 있지만, 최근 경쟁 심화로 어려움을 겪고 있습니다. 특히 브라질과 아르헨티나 시장에서 신규 진입 기업들의 경쟁이 격화되면서 매출 성장률이 둔화되고 있습니다. 그러나 MercadoLibre는 디지털 결제 플랫폼인 Mercado Pago를 통해 다양한 수익원을 확보하고 있어, 장기적인 안정성을 유지할 가능성이 있습니다.

본문 3: Visa의 글로벌 전략

Visa는 글로벌 결제 시장 점유율 20% 이상을 차지하고 있으며, 특히 신흥 시장에서의 성장 잠재력이 높습니다. 2025년 기준 3,000억 달러 이상의 매출을 기록한 Visa는, 디지털 결제 트렌드의 확대로 인해 장기적인 성장 전망이 밝습니다. 그러나 경쟁사들과의 가격 경쟁이 심화되면서 수익률이 압박받을 가능성도 있습니다.

결론

HCA Healthcare, MercadoLibre, Visa는 단기적인 어려움을 겪고 있지만, 각각의 시장 우위와 성장 잠재력을 고려할 때 장기 투자용으로 적합합니다. 특히 HCA Healthcare의 노령화 인구 증가라는 세속적 추세와 MercadoLibre의 디지털 결제 플랫폼, Visa의 글로벌 시장 점유율이 주요 투자 포인트로 부각됩니다. 향후 경제 상황과 기업의 전략적 대응을 주시할 필요가 있습니다.

---

원문 링크: https://www.fool.com/investing/2026/06/27/3-surefire-stocks-to-buy-on-the-dip-and-hold-for-a/?.tsrc=rss

3 Surefire Stocks to Buy on the Dip and Hold for a Decade

Broader equities have been resilient this year. Despite many challenges, the S&P 500 has climbed by a healthy 7% to date. However, some stocks haven't been so lucky and are experiencing steep declines due to company-specific issues. Take HCA Healthcare ( HCA +1.27% ) , MercadoLibre ( MELI +3.59% ) , and Visa ( V +2.04% ) . All three of these corporations may be leaders in their respective industries, but they have faced obstacles that have sent their share prices down. But the good news is that HCA Healthcare, MercadoLibre, and Visa are all worth serious consideration on the dip. Let me explain.

HCA Healthcare performed well last year, but things are looking very different in 2026 for the healthcare facility operator. Its shares have fallen partly due to various economic challenges affecting its financial results. We aren't out of the woods yet, either. Inflation remains high, some economists still fear a recession may be coming, and although geopolitical tensions have eased, that may or may not last. Even in this shaky environment, though, HCA Healthcare is a top pick for long-term investors.

Here are three reasons why. First, HCA Healthcare is a leader in its niche and boasts a large network of facilities throughout much of the U.S. The industry is protected by steep barriers to entry, including the high upfront costs of building facilities and the various regulatory hurdles companies must navigate. HCA Healthcare has an advantage as an established industry leader.

Second, even among its peers, HCA Healthcare has imposed itself. The company has increased its market share over the years, partly thanks to improvements in cutting-edge technology that attract patients. Third, HCA Healthcare should benefit from secular tailwinds, such as the world's aging population, which will drive increased demand for its services. All these factors (and more) make the stock an attractive one to buy on the dip and hold onto for a while.

MercadoLibre has faced increased competition in the e-commerce market in Latin America in recent years. The company has responded by investing heavily in various initiatives that management thinks will eventually pay rich dividends. Unfortunately, the spending is leading to lower profits and margins in the short term, and many investors aren't happy about that. It is one of the key reasons the stock has underperformed broader equities over the past 12 months.

But is that really justified? After all, MercadoLibre is looking to tap into massive opportunities. For instance, as the company argues, many people in the regions it operates are underbanked. It has poured money into expanding its financial services . That won't pay off immediately -- at least not in terms of stronger margins -- but over the long run, it could help MercadoLibre establish itself as a leading financial institution.

MercadoLibre has also invested in initiatives that have proven successful, such as lowering the threshold for free shipping on its e-commerce platform. This can help boost the company's gross merchandise volume and sales and expand its ecosystem, even with lower profits in the near term. Elsewhere, MercadoLibre is ramping up high-margin opportunities, such as its advertising business. My view is that the sell-off is overdone, and given MercadoLibre's current efforts, the company is likely to bounce back eventually and offer excellent returns to patient investors.

Visa is facing headwinds due to legal and regulatory challenges. It is the subject of an antitrust lawsuit in the U.S. Also, a proposed bill aims to break the duopoly it holds with Mastercard ( MA +2.07% ) . There is no question that these obstacles make the company's prospects somewhat uncertain. However, if we put all that aside for a second, Visa's business remains strong. The company's financial results have been solid, and it holds a wide moat due to network effects, as customers and businesses increasingly seek one another within the company's ecosystem of credit and debit cards, whose transactions it helps process.

The more cards in circulation with Visa's logo, the stronger its network effect. Meanwhile, Visa is still looking at a large worldwide opportunity to bring cash and check transactions into its ecosystem, while it could also benefit from the growth of the e-commerce industry, where digital payment methods are the norm.

Legal issues likely won't completely go away, but it's worth noting that antitrust lawsuits don't have a great track record of breaking up businesses in the U.S., as we recently saw with the Alphabet ( GOOG 2.19% ) ( GOOGL 1.73% ) case. And although a proposed bill could disrupt the company's operations, there is also no guarantee it will pass. Investors should definitely keep those potential headwinds in mind, but Visa could still generate outstanding returns over the long run. The company lagging broader equities over the past year -- despite strong financial results -- suggests the challenges it faces are already somewhat baked into the stock price. That's why its shares are still worth buying.

Source: https://www.fool.com/investing/2026/06/27/3-surefire-stocks-to-buy-on-the-dip-and-hold-for-a/?.tsrc=rss